Mid-Year Announcement In the first half of this year, we've deployed $19,620,000 in eleven groundbreaking companies across seven municipalities, impacting Puerto Rico from shore to shore. We will continue to deploy capital throughout the remainder of the year to entrepreneurs doing research and development on the island. The innovation ecosystem would not be possible without the of both the public and private sectors, and we are honored to be part of that group. We are bullish on Puerto Rico and trust in the founders building here. Stay tuned for more updates on the Puerto Rico Innovation Fund.
Puerto Rico Innovation Fund
Gestión de inversiones
Empowering Puerto Rico’s game-changers and fueling innovation through strategic capital.
Sobre nosotros
The Puerto Rico Innovation Fund (PRIF) provides attractive financing for innovative companies in Puerto Rico conducting R&D activities. The Puerto Rico Innovation Fund provides competitive financing options to research and development within Puerto Rico's dynamic business sector. Specializing in loans from $500,000 to over $10 million, PRIF focuses on propelling growth in industries such as Biotechnology, Pharmaceuticals, Software, Renewable Energy, and Advanced Manufacturing. With a strong commitment to innovation and economic development, PRIF is dedicated to enabling companies to reach their full potential and establish Puerto Rico as a hub of technological advancement.
- Sitio web
-
https://www.prinnovationfund.com/
Enlace externo para Puerto Rico Innovation Fund
- Sector
- Gestión de inversiones
- Tamaño de la empresa
- De 2 a 10 empleados
- Sede
- San Juan
- Tipo
- Asociación
Ubicaciones
-
Principal
Cómo llegar
San Juan, PR
Empleados en Puerto Rico Innovation Fund
-
John B. Pelling III
Director of Capital Markets - DECA Analytics | Managing Partner - Puerto Rico Innovation Fund
-
Philip Gaucher
Co-Head of Investment Banking, RBW Capital Partners | Managing Partner, PRIF
-
Colton Wandke, CAIA
Co-Founder & Partner - DECA | Partner - PR Innovation Fund
Actualizaciones
-
Puerto Rico Innovation Fund ha compartido esto
At the BIO International Convention 2024, our team was able to engage in over 150 one-on-one meetings, highlighting a strong interest in reshoring R&D and manufacturing activities to Puerto Rico due to its supply chain resilience, regulatory compliance, market access, and intellectual property protections. The Island’s historical role in pharmaceutical and medical device manufacturing, along with attractive tax incentives and a skilled bilingual workforce, are all crucial reasons to consider Puerto Rico. Overall, the enthusiasm for Puerto Rico as a biotech hub was extremely evident. A special thanks to Invest Puerto Rico for organizing such an amazing delegation representing both the public and private sectors. In the article are our key takeaways.